cGxP.wire https://validator.w3.org/feed/docs/rss2.html Arrowhead REDEMPLO siRNA Drug Approved in Australia Harvard Study Shows AI Outperforms Doctors in Diagnosis Moleculent Raises $20M to Scale Functional Profiling Platform Alcresta Therapeutics Shows RELiZORBneo Benefit Data InspireMD Initiates U.S. Recall of CGuard Prime System Incyte Corporation Wins FDA Approval for Jakafi XR InspireMD, Inc. Secures FDA IDE for CGUARDIANS III Viatris Low-Dose Estrogen Patch Phase 3 Data Update Merck Enpatoran Enters Phase 3 Trial for Lupus Treatment Vector Science & Therapeutics Files Patent for Platform Everads Injector Shows Strong Results in Retinal Study Specialised Therapeutics NIKTIMVO Approved for cGVHD Sydnexis, Inc. Advances SYD-101 Data in Myopia Trial Rezolute, Inc. Reports Phase 3 sunRIZE Data in HI Eton Pharmaceuticals Relaunches HEMANGEOL for Infants MapLight Therapeutics Completes Phase 2 CNS Trials Enrollment Neurocrine CRENESSITY Shows 2-Year Pediatric Benefits BioMarin VOXZOGO Shows Long-Term Growth Benefits Cue Biopharma Expands Anti-IgE Pipeline in $691M Deal SK Capital Partners Sells Noramco Group to Siegfried Scribe Therapeutics Showcases CRISPR and STX-1150 Data Arvinas Inc Gains FDA Approval for VEPPANU PROTAC Drug Sonire Therapeutics Launches U.S. HIFU Trial in Cancer Apotex Gains Canada Approval for Generic Ozempic Rhythm Pharmaceuticals Secures EU Approval for IMCIVREE Kodiak KSI-101 Shows Strong MESI Clinical Trial Results Noema Pharma AG Shows Strong Phase 2a Menopause Results LEO Pharma Acquires Replay to Boost Gene Therapy Guardant Health, Nuvalent Partner in Precision Oncology Larimar Therapeutics Validates Skin Biomarker in FA Contineum Therapeutics Reports Positive PIPE-791 Data Keenova TERLIVAZ Real-World Data Advances HRS-AKI Care Zeta Surgical Wins FDA Clearance for Neuro Navigation Corcept Therapeutics Reports ALS Survival Breakthrough MRM Health Launches Phase 2b UC Trial with MH002 Vanda Launches NEREUS First Motion Sickness Drug Pfizer ELREXFIO Phase 3 Trial Improves Survival Outcomes Diakonos Oncology Reports Phase 1 DOC1021 Survival Data AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer Pluristyx and Qkine Sign Strategic iPSC Distribution Deal Bambusa Therapeutics Completes BBT001 Trial Enrollment SetPoint Medical Starts MS Study for Neuroimmune Therapy BeOne Medicines Gains FDA Priority Review for TEVIMBRA Kernal Biologics Showcases mRNA 2.0 CAR-T Platform Neurocrine Defines TDIS Threshold for TD Treatment Impact Iterative Health Secures $77M to Accelerate Clinical Trials Huahui Health, BeOne Strike $2B HH160 Oncology Deal Made Scientific Expands Board for Cell Therapy Scale-Up OS Therapies Secures EMA Review for OST-HER2 Drug Theradaptive Gains FDA Approval for Regenerative Spine Therapy